- Home
- FSP vs GNFT Comparison
FSP vs GNFT Comparison
Compare FSP & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSP
- GNFT
- Stock Information
- Founded
- FSP 1981
- GNFT 1999
- Country
- FSP United States
- GNFT France
- Employees
- FSP N/A
- GNFT N/A
- Industry
- FSP Real Estate Investment Trusts
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FSP Real Estate
- GNFT Health Care
- Exchange
- FSP Nasdaq
- GNFT Nasdaq
- Market Cap
- FSP 187.5M
- GNFT 179.7M
- IPO Year
- FSP N/A
- GNFT 2019
- Fundamental
- Price
- FSP $1.76
- GNFT $3.74
- Analyst Decision
- FSP
- GNFT Strong Buy
- Analyst Count
- FSP 0
- GNFT 1
- Target Price
- FSP N/A
- GNFT $13.00
- AVG Volume (30 Days)
- FSP 229.5K
- GNFT 9.9K
- Earning Date
- FSP 02-24-2025
- GNFT 09-19-2024
- Dividend Yield
- FSP 2.26%
- GNFT N/A
- EPS Growth
- FSP N/A
- GNFT N/A
- EPS
- FSP N/A
- GNFT 0.47
- Revenue
- FSP $126,508,000.00
- GNFT $86,225,222.00
- Revenue This Year
- FSP N/A
- GNFT $145.20
- Revenue Next Year
- FSP $0.02
- GNFT N/A
- P/E Ratio
- FSP N/A
- GNFT $7.89
- Revenue Growth
- FSP N/A
- GNFT 175.45
- 52 Week Low
- FSP $1.47
- GNFT $3.35
- 52 Week High
- FSP $2.47
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- FSP 46.08
- GNFT 49.41
- Support Level
- FSP $1.75
- GNFT $3.68
- Resistance Level
- FSP $1.88
- GNFT $4.03
- Average True Range (ATR)
- FSP 0.06
- GNFT 0.15
- MACD
- FSP -0.00
- GNFT 0.05
- Stochastic Oscillator
- FSP 26.13
- GNFT 57.35
About FSP Franklin Street Properties Corp.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.